About Molecular Sensing
Molecular Sensing, Inc. (MSI), an early stage company located in the San Francisco Bay area, is dedicated to commercializing a new ,"game changing" molecular interaction biosensor technology, Back-Scattering Interferometry (BSI). BSI was invented by leading researchers at Vanderbilt University and addresses unmet needs in pharmaceutical drug discovery & development, biomedical research, and diagnostics. BSI overcomes the limitations of SPR and ITC, while combining their advantages in a single, synergistic platform.
Facts about Molecular Sensing
Facts about Molecular Sensing
- Focus : Service
- Industry : Pharma
Product portfolio of Molecular Sensing
Here you will find Molecular Sensing Inc.
Last viewed contents
Laminaria
Pharmaprojects - Pharmaceutical Research & Development Pipeline Intelligence - Informa UK Ltd - London, United Kingdom
National Center for Drug Screening (NCDS) - Shanghai, China
Clavis Pharma and Clovis Oncology Extend Partnership and Sign New $205 Million Deal for Development and Commercialisation
WISAG Wissenschaftliche Apparaturen und Industrieanlagen AG - Zürich, Switzerland
Roche acquires NimbleGen to gain entry into high-growth research microarrray market
